Peptidylprolyl isomerase A pseudogene 2 (PPIAP2)

Peptidylprolyl isomerase A pseudogene 2 (PPIAP2), abbreviated as PPIAP2 and also known as bA384D7.2, is classified as a human pseudogene and a subtype of long non-coding RNA (lncRNA)[1][3]. Pseudogenes are genomic elements that resemble protein-coding genes but generally do not encode functional proteins due to mutations, truncations, or lack of necessary regulatory elements[5]. Although some pseudogenes have been shown to participate in gene regulation or cellular processes by acting as competitive endogenous RNAs or affecting gene expression[3][5][6], there is currently no evidence that PPIAP2 has a defined biological function, therapeutic relevance, or disease association. It should not be confused with peptidylprolyl isomerase A (PPIA), which encodes a functional enzyme with well-characterized roles in protein folding, immunity, and disease[2][3][4]. PPIAP2 remains a genomic element of interest but is not an established therapeutic target or biomarker. If you require information on a specific peptidylprolyl isomerase protein (e.g., PPIA/cyclophilin A) or another pseudogene with functional or clinical importance (such as PPIAP22), please specify, as the information above applies strictly to PPIAP2[1][3][4].

Other names

bA384D7.2

None. No mechanism of drug action is defined for PPIAP2.